We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Class I Recall Increase Reflects a Fundamental Policy Shift at FDA
Class I Recall Increase Reflects a Fundamental Policy Shift at FDA
October 27, 2006
The FDA’s decision to perform 45 Class I recalls over the past year signals a fundamental shift in enforcement policy for an agency still reeling from criticism over recent drug safety incidents, sources say.